Molnupiravir in Combination With Nirmatrelvir/Ritonavir: No Cause for Alarm
J Infect Dis
.
2024 Dec 16;230(6):1297-1298.
doi: 10.1093/infdis/jiae214.
Author
Daniel R Kuritzkes
1
Affiliation
1
Division of Infectious Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
PMID:
38973073
PMCID:
PMC11646577
(available on
2025-07-08
)
DOI:
10.1093/infdis/jiae214
No abstract available
Keywords:
COVID-19; SARS-CoV-2; antiviral drugs; drug resistance; error catastrophe.
Publication types
Editorial
Comment
Grants and funding
UM1 AI069412/AI/NIAID NIH HHS/United States